Related Experiment Video
Updated: Oct 19, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Human genetic basis of coronavirus disease 2019
Hao Deng1,2,3,4, Xue Yan5,6,7, Lamei Yuan5,6,7,8
1Health Management Center, the Third Xiangya Hospital, Central South University, Changsha, China. hdeng008@yahoo.com.
Insights
Host genetic factors influence COVID-19 outcomes. Understanding genetic diversity in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can aid in predicting disease severity and developing targeted therapies.
Area of Science:
- Genetics
- Immunology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has led to significant global morbidity and mortality.
- Observed disparities in COVID-19 incidence, severity, and mortality across diverse populations suggest multifactorial influences, including host genetics.
- Individual susceptibility and disease outcomes are influenced by a complex interplay of genetic factors.
Purpose of the Study:
- To review the clinical and viral characteristics of COVID-19.
- To explore the pathogenesis of SARS-CoV-2 infection.
- To highlight genetic findings, focusing on genetic diversity and variants in relation to COVID-19 outcomes.
Main Methods:
- This review synthesizes existing literature on COVID-19.
- It examines host genetic factors, including ACE, ACE2, TMPRSS2 gene variants, HLA genotypes, and ABO blood groups.
- The review focuses on the impact of genetic diversity and variants on disease characteristics.
Main Results:
- Host genetic factors, such as variants in ACE, ACE2, TMPRSS2, HLA genotype, and ABO blood group, play a role in individual susceptibility, severity, and outcomes of COVID-19.
- Genetic diversity and specific variants contribute to the heterogeneous presentation of SARS-CoV-2 infection.
- These genetic underpinnings offer insights into differential disease risk and progression.
Conclusions:
- The human genetic basis of COVID-19 is crucial for understanding disease heterogeneity.
- Identifying genetic predispositions can inform disease prediction models.
- Genetic insights hold potential for developing targeted therapeutic strategies against COVID-19.
Abstract:
Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in considerable morbidity and mortality worldwide. COVID-19 incidence, severity, and mortality rates differ greatly between populations, genders, ABO blood groups, human leukocyte antigen (HLA) genotypes, ethnic groups, and geographic backgrounds. This highly heterogeneous SARS-CoV-2 infection is multifactorial. Host genetic factors such as variants in the angiotensin-converting enzyme gene (ACE), the angiotensin-converting enzyme 2 gene (ACE2), the transmembrane protease serine 2 gene (TMPRSS2), along with HLA genotype, and ABO blood group help to explain individual susceptibility, severity, and outcomes of COVID-19. This review is focused on COVID-19 clinical and viral characteristics, pathogenesis, and genetic findings, with particular attention on genetic diversity and variants. The human genetic basis could provide scientific bases for disease prediction and targeted therapy to address the COVID-19 scourge.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Viral Mutations
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Incomplete Dominance
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

